Vaccins contre les hépatites virales : Questions médicales fréquentes
Nom anglais: Viral Hepatitis Vaccines
Descriptor UI:D014761
Tree Number:D20.215.894.899.955
Termes MeSH sélectionnés :
Social Interaction
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les hépatites virales : Questions médicales les plus fréquentes",
"headline": "Vaccins contre les hépatites virales : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vaccins contre les hépatites virales : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-21",
"dateModified": "2025-05-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vaccins contre les hépatites virales"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Vaccins antiviraux",
"url": "https://questionsmedicales.fr/mesh/D014765",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins antiviraux",
"code": {
"@type": "MedicalCode",
"code": "D014765",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccins anti-hépatite A",
"alternateName": "Hepatitis A Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022362",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins anti-hépatite A",
"code": {
"@type": "MedicalCode",
"code": "D022362",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.955.395"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins anti-hépatite B",
"alternateName": "Hepatitis B Vaccines",
"url": "https://questionsmedicales.fr/mesh/D017325",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins anti-hépatite B",
"code": {
"@type": "MedicalCode",
"code": "D017325",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.955.400"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les hépatites virales",
"alternateName": "Viral Hepatitis Vaccines",
"code": {
"@type": "MedicalCode",
"code": "D014761",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Christoph Neumann-Haefelin",
"url": "https://questionsmedicales.fr/author/Christoph%20Neumann-Haefelin",
"affiliation": {
"@type": "Organization",
"name": "Klinik für Innere Medizin II - Gastroenterologie, Hepatologie, Endokrinologie, Infektiologie, Universitätsklinikum Freiburg, Freiburg, Deutschland."
}
},
{
"@type": "Person",
"name": "Robert Thimme",
"url": "https://questionsmedicales.fr/author/Robert%20Thimme",
"affiliation": {
"@type": "Organization",
"name": "Klinik für Innere Medizin II - Gastroenterologie, Hepatologie, Endokrinologie, Infektiologie, Universitätsklinikum Freiburg, Freiburg, Deutschland. robert.thimme@uniklinik-freiburg.de."
}
},
{
"@type": "Person",
"name": "Maria Buti",
"url": "https://questionsmedicales.fr/author/Maria%20Buti",
"affiliation": {
"@type": "Organization",
"name": "Liver Unit, Hospital Universitario Valle Hebron and Civerehd del Instituto Carlos III, Barcelona, Spain."
}
},
{
"@type": "Person",
"name": "Stefan Zeuzem",
"url": "https://questionsmedicales.fr/author/Stefan%20Zeuzem",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine 1, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany."
}
},
{
"@type": "Person",
"name": "Fabien Zoulim",
"url": "https://questionsmedicales.fr/author/Fabien%20Zoulim",
"affiliation": {
"@type": "Organization",
"name": "INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon, Lyon, France."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Duet synchronization interventions affect social interactions.",
"datePublished": "2024-04-30",
"url": "https://questionsmedicales.fr/article/38688922",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-60485-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Intertwining the social and the cognitive loops: socially enactive cognition for human-compatible interactive systems.",
"datePublished": "2023-03-06",
"url": "https://questionsmedicales.fr/article/36871585",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1098/rstb.2021.0474"
}
},
{
"@type": "ScholarlyArticle",
"name": "Examining the social in the prosocial: Episode-level features of social interactions and kind acts predict social connection and well-being.",
"datePublished": "2023-05-01",
"url": "https://questionsmedicales.fr/article/37126042",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1037/emo0001232"
}
},
{
"@type": "ScholarlyArticle",
"name": "Social interaction, psychotic disorders and inflammation: A triangle of interest.",
"datePublished": "2022-12-12",
"url": "https://questionsmedicales.fr/article/36521587",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.pnpbp.2022.110697"
}
},
{
"@type": "ScholarlyArticle",
"name": "More Interactions, More Prosociality? An Investigation of the Prosocial Effect of Online Social Interactions Among Adolescents.",
"datePublished": "2022-05-20",
"url": "https://questionsmedicales.fr/article/35594300",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1089/cyber.2021.0343"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Mélanges complexes",
"item": "https://questionsmedicales.fr/mesh/D045424"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits biologiques",
"item": "https://questionsmedicales.fr/mesh/D001688"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vaccins",
"item": "https://questionsmedicales.fr/mesh/D014612"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vaccins antiviraux",
"item": "https://questionsmedicales.fr/mesh/D014765"
},
{
"@type": "ListItem",
"position": 6,
"name": "Vaccins contre les hépatites virales",
"item": "https://questionsmedicales.fr/mesh/D014761"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vaccins contre les hépatites virales - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vaccins contre les hépatites virales",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vaccins contre les hépatites virales",
"description": "Quels sont les symptômes de l'hépatite A ?\nL'hépatite B peut-elle être asymptomatique ?\nComment se manifeste l'hépatite C ?\nQuels signes indiquent une hépatite aiguë ?\nL'hépatite virale peut-elle causer des complications ?",
"url": "https://questionsmedicales.fr/mesh/D014761?mesh_terms=Social+Interaction&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vaccins contre les hépatites virales",
"description": "Comment les vaccins contre l'hépatite A sont-ils administrés ?\nQui devrait recevoir le vaccin contre l'hépatite B ?\nLes vaccins contre l'hépatite A sont-ils efficaces ?\nÀ quel âge doit-on vacciner les enfants contre l'hépatite B ?\nLes voyageurs doivent-ils se faire vacciner contre l'hépatite A ?",
"url": "https://questionsmedicales.fr/mesh/D014761?mesh_terms=Social+Interaction&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vaccins contre les hépatites virales",
"description": "Quel est le traitement de l'hépatite A ?\nComment traite-t-on l'hépatite B chronique ?\nL'hépatite C est-elle curable ?\nQuels médicaments sont utilisés pour l'hépatite B ?\nY a-t-il un vaccin pour l'hépatite C ?",
"url": "https://questionsmedicales.fr/mesh/D014761?mesh_terms=Social+Interaction&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vaccins contre les hépatites virales",
"description": "Quelles sont les complications de l'hépatite B ?\nL'hépatite A peut-elle causer des complications ?\nQuels risques sont associés à l'hépatite C ?\nComment prévenir les complications de l'hépatite ?\nLes complications de l'hépatite peuvent-elles être réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D014761?mesh_terms=Social+Interaction&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vaccins contre les hépatites virales",
"description": "Quels sont les facteurs de risque pour l'hépatite A ?\nQui est à risque d'hépatite B ?\nL'hépatite C est-elle transmissible par le sang ?\nLes travailleurs de la santé sont-ils à risque d'hépatite ?\nLes personnes atteintes de maladies chroniques sont-elles plus à risque ?",
"url": "https://questionsmedicales.fr/mesh/D014761?mesh_terms=Social+Interaction&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Quels sont les symptômes de l'hépatite A ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, nausées, douleurs abdominales et jaunisse."
}
},
{
"@type": "Question",
"name": "L'hépatite B peut-elle être asymptomatique ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreuses personnes infectées par l'hépatite B ne présentent pas de symptômes."
}
},
{
"@type": "Question",
"name": "Comment se manifeste l'hépatite C ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure fatigue, douleurs articulaires et jaunisse, mais souvent absents."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une hépatite aiguë ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une forte fièvre, des douleurs abdominales et une urine foncée."
}
},
{
"@type": "Question",
"name": "L'hépatite virale peut-elle causer des complications ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications comme la cirrhose ou le cancer du foie peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les vaccins contre l'hépatite A sont-ils administrés ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont généralement administrés par injection intramusculaire en deux doses."
}
},
{
"@type": "Question",
"name": "Qui devrait recevoir le vaccin contre l'hépatite B ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est recommandé pour tous les nourrissons, les enfants et les adultes à risque."
}
},
{
"@type": "Question",
"name": "Les vaccins contre l'hépatite A sont-ils efficaces ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils offrent une protection d'environ 95% après la vaccination complète."
}
},
{
"@type": "Question",
"name": "À quel âge doit-on vacciner les enfants contre l'hépatite B ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination doit commencer à la naissance, avec des doses supplémentaires à 1 et 6 mois."
}
},
{
"@type": "Question",
"name": "Les voyageurs doivent-ils se faire vacciner contre l'hépatite A ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la vaccination est recommandée pour les voyageurs se rendant dans des zones à risque."
}
},
{
"@type": "Question",
"name": "Quel est le traitement de l'hépatite A ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement spécifique ; le repos et l'hydratation sont recommandés."
}
},
{
"@type": "Question",
"name": "Comment traite-t-on l'hépatite B chronique ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antiviraux peuvent être prescrits pour contrôler l'infection et prévenir les complications."
}
},
{
"@type": "Question",
"name": "L'hépatite C est-elle curable ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements antiviraux modernes peuvent guérir l'hépatite C dans la plupart des cas."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour l'hépatite B ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les médicaments comme le ténofovir et l'entécavir sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Y a-t-il un vaccin pour l'hépatite C ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin efficace contre l'hépatite C."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications de l'hépatite B ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la cirrhose, le cancer du foie et l'insuffisance hépatique."
}
},
{
"@type": "Question",
"name": "L'hépatite A peut-elle causer des complications ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rarement, mais des complications comme l'insuffisance hépatique peuvent survenir chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à l'hépatite C ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hépatite C peut entraîner des maladies hépatiques chroniques et des cancers du foie."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications de l'hépatite ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination, le dépistage régulier et un mode de vie sain aident à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Les complications de l'hépatite peuvent-elles être réversibles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications, comme la fibrose, peuvent être réversibles avec un traitement approprié."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour l'hépatite A ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le voyage dans des zones à risque et la consommation d'eau contaminée."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'hépatite B ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes ayant des rapports sexuels non protégés et les utilisateurs de drogues injectables sont à risque."
}
},
{
"@type": "Question",
"name": "L'hépatite C est-elle transmissible par le sang ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hépatite C se transmet principalement par le sang, notamment via les transfusions."
}
},
{
"@type": "Question",
"name": "Les travailleurs de la santé sont-ils à risque d'hépatite ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont exposés à un risque accru d'infection par contact avec le sang."
}
},
{
"@type": "Question",
"name": "Les personnes atteintes de maladies chroniques sont-elles plus à risque ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent avoir un risque accru de complications liées à l'hépatite."
}
}
]
}
]
}
Humans' complex behavior, such as speech, music, or dance, requires us to coordinate our actions with external sounds as well as with social partners. The presence of a partner can influence individua...
It is increasingly important for technical systems to be able to interact flexibly, robustly and fluently with humans in real-world scenarios. However, while current AI systems excel at narrow task co...
Experiments prompting people to engage in more prosocial behavior (e.g., acts of kindness) or simple social interactions (e.g., acting extraverted) have both shown promise in boosting well-being. Howe...
Social interaction difficulties are a hallmark of psychotic disorders, which in some cases can be definitely traced back to autoimmunological causes. Interestingly, systemic and intrathecal inflammati...
Adolescence is a key stage for prosocial advancement. A plethora of research suggested that the consumption of prosocial-themed media content can facilitate the development of adolescents' prosocialit...
Theories of embodied cognition suggest that a shared environment and ongoing sensorimotor interaction are central for interpersonal learning and engagement. To investigate the embodied, distributed an...
Prior hyperscanning studies that record the brain activities of caregivers and children concurrently have primarily been conducted within the confines of the laboratory, thus limiting the generalizabi...
The understanding of developing social brain functions during infancy relies on research that has focused on studying how infants engage in first-person social interactions or view individual agents a...
Interoception, that is, the perception of visceral stimuli, is the basis of socio-emotional development. However, no studies have demonstrated the relationship between the two in infants. This study a...
Navigating workplace social interactions can be stressful for autistic people and be experienced differently by gender. A better understanding of the autistic experience of these difficulties is neede...
Fifty-five autistic individuals (n women=32; n men=22) participated in either an online survey or focus group. Data were analyzed using inductive thematic analysis....
The data suggests that the social and interaction expectations placed upon autistic individuals differ by gender and can contribute to occupational stress....
The data provides a basis for further investigation considering Conservation of Resources Theory and its practical application to inform reasonable adjustments in the workplace for autistic people....
The gendered workplace experiences of autistic people is an emerging area of research. However, how workplace social interactions are experienced by each gender remains under-researched. An understand...